Status:

TERMINATED

Study of XL999 in Patients With Metastatic Colorectal Cancer

Lead Sponsor:

Symphony Evolution, Inc.

Conditions:

Colorectal Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This clinical study is being conducted at multiple sites to determine the activity, safety, and tolerability of XL999 when given weekly to patients with metastatic colorectal cancer (CRC). XL999 is a ...

Eligibility Criteria

Inclusion

  • Males and females with histologically confirmed metastatic colorectal cancer
  • Measurable disease according to Response Criteria for Solid Tumors (RECIST)
  • At least 1 prior therapeutic regimen (chemotherapy or biologic)
  • ECOG performance status of 0 or 1
  • Life expectancy ≥3 months
  • Adequate organ and marrow function
  • No other malignancies within 5 years
  • Signed informed consent

Exclusion

  • Radiation to ≥25% of bone marrow within 30 days of XL999 treatment
  • Treatment with systemic anticancer therapy within 30 days of XL999 treatment
  • Subject has not recovered to ≤ grade 1 or to within 10% of baseline from adverse events due to other medications administered \>30 days prior to study enrollment
  • History of or known brain metastases, current spinal cord compression, or carcinomatous meningitis
  • Uncontrolled and/or intercurrent illness
  • Pregnant or breastfeeding females
  • Known HIV

Key Trial Info

Start Date :

December 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2007

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT00277303

Start Date

December 1 2005

End Date

February 1 2007

Last Update

February 22 2010

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

California Cancer Care, Inc.

Greenbrae, California, United States, 94904

2

Integrated Community Oncology Network; Division of Clinical Research

Jacksonville, Florida, United States, 32256

3

Hematology Oncology Associated of the Treasure Coast

Port Saint Lucie, Florida, United States, 34952

4

University of Chicago

Chicago, Illinois, United States, 60637